The Venture Codex Logo

The Venture Codex

PhaseBio Pharmaceuticals

1 Great Valley Parkway, Suite 30, Malvern, PA, 19355, United States

Overview

Clinical-stage biopharmaceutical company developing drugs for metabolic dis

Total Raised

$167 M

Rounds

8

Links

Verticals

Biotechnology
Medical
Medical Device
Pharmaceutical

Investment History

  1. Series D

    Sep 2018

    $34M

    Cormorant Asset ManagementRock Springs CapitalFletcher Spaght VenturesHatteras Venture PartnersSyno CapitalJohnson & Johnson InnovationMountain Group PartnersAstraZenecaNew Enterprise Associates

  2. Debt Financing

    Nov 2017

    $8M

    Silicon Valley Bank · Lead

  3. Convertible Note

    Jan 2017

    $15M

    Johnson & Johnson InnovationFletcher Spaght VenturesSyno CapitalAstraZenecaHatteras Venture PartnersNew Enterprise Associates

  4. Series C

    Mar 2015

    $40M

    AstraZeneca · LeadHatteras Venture PartnersJohnson & Johnson InnovationFletcher Spaght VenturesNew Enterprise Associates

  5. Series B

    Jun 2012

    $23M

    Hatteras Venture PartnersFletcher Spaght VenturesAstellas Venture ManagementNew Enterprise AssociatesJohnson & Johnson Innovation

Team

Christopher Prior

CEO

Jonathan Mow

Chief Executive Officer

Ashutosh Chilkoti

Founder & Board Member

Craig A. Rosen

Executive Chairman & CSO